Genetic testing in familial and young-onset Alzheimer's disease: mutation spectrum in a Serbian cohort

被引:19
作者
Dobricic, Valerija [3 ]
Stefanova, Elka [3 ,4 ]
Jankovic, Milena [4 ]
Gurunlian, Nicole [1 ,2 ]
Novakovic, Ivana [3 ,4 ]
Hardy, John [1 ,2 ]
Kostic, Vladimir [3 ,4 ]
Guerreiro, Rita [1 ,2 ]
机构
[1] Inst Neurol, Reta Lilla Weston Labs, London WC1N 3BG, England
[2] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England
[3] Clin Ctr Serbia, Inst Neurol, Belgrade, Serbia
[4] Univ Belgrade, Sch Med, Belgrade, Serbia
基金
英国医学研究理事会;
关键词
Alzheimer's disease; Mutations; Serbia; Presenilins; APP; GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; MISSENSE MUTATIONS; PROTEIN; PRESENILIN-1; ALLELE; APP; CLU;
D O I
10.1016/j.neurobiolaging.2011.12.007
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Alzheimer's disease (AD) is the most common form of dementia. To date, more than 200 mutations in three genes have been identified as cause of early-onset autosomal dominant inherited AD. The aim of this study was to characterize the mutation spectrum and describe genotype-phenotype correlations in Serbian patients with positive family history of AD or/and early-onset AD. We performed a genetic screening for mutations in the coding regions of Presenilins 1 and 2 (PSEN1 and PSEN2), as well as exons 16 and 17 of the Amyloid Precursor Protein gene (APP) in a total of 47 patients from Serbia with a clinical diagnosis of familial and/or early-onset AD (mean age at onset of 60.3 years; range 32-77). We found one novel mutation in PSEN1, one novel variant in PSEN2, and three previously described variants, one in each of the analyzed genes. Interestingly, we identified one patient harboring two heterozygous mutations: one in APP (p.L723P) and one in PSEN1 (p.R108Q). (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页数:6
相关论文
共 34 条
[1]  
Alzheimer A, 1995, Clin Anat, V8, P429
[2]  
[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[3]  
[Anonymous], NEUROBIOL AGING 0629
[4]   A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families [J].
Athan, ES ;
Williamson, J ;
Ciappa, A ;
Santana, V ;
Romas, SN ;
Lee, JH ;
Rondon, H ;
Lantigua, RA ;
Medrano, M ;
Torres, M ;
Arawaka, S ;
Rogaeva, E ;
Song, YQ ;
Sato, C ;
Kawarai, T ;
Fafel, KC ;
Boss, MA ;
Seltzer, WK ;
Stern, Y ;
St George-Hyslop, P ;
Tycko, B ;
Mayeux, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (18) :2257-2263
[5]   GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES [J].
CORDER, EH ;
SAUNDERS, AM ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
SCIENCE, 1993, 261 (5123) :921-923
[6]   Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population based study of presenile Alzheimer disease [J].
Cruts, M ;
van Duijn, CM ;
Backhovens, H ;
Van den Broeck, M ;
Wehnert, A ;
Serneels, S ;
Sherrington, R ;
Hutton, M ;
Hardy, J ;
St George-Hyslop, PH ;
Hofman, A ;
Van Broeckhoven, C .
HUMAN MOLECULAR GENETICS, 1998, 7 (01) :43-51
[7]   Transgenic models for Alzheimer's disease [J].
Duff, K .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1998, 24 (02) :101-103
[8]   ALZHEIMERS-DISEASE - INITIAL REPORT OF THE PURIFICATION AND CHARACTERIZATION OF A NOVEL CEREBROVASCULAR AMYLOID PROTEIN [J].
GLENNER, GG ;
WONG, CW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (03) :885-890
[9]   SEGREGATION OF A MISSENSE MUTATION IN THE AMYLOID PRECURSOR PROTEIN GENE WITH FAMILIAL ALZHEIMERS-DISEASE [J].
GOATE, A ;
CHARTIERHARLIN, MC ;
MULLAN, M ;
BROWN, J ;
CRAWFORD, F ;
FIDANI, L ;
GIUFFRA, L ;
HAYNES, A ;
IRVING, N ;
JAMES, L ;
MANT, R ;
NEWTON, P ;
ROOKE, K ;
ROQUES, P ;
TALBOT, C ;
PERICAKVANCE, M ;
ROSES, A ;
WILLIAMSON, R ;
ROSSOR, M ;
OWEN, M ;
HARDY, J .
NATURE, 1991, 349 (6311) :704-706
[10]   Very early-onset familial Alzheimer's disease: a novel presenilin 1 mutation [J].
Goldman, JS ;
Reed, B ;
Gearhart, R ;
Kramer, JH ;
Miller, BL .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2002, 17 (07) :649-651